Rick Simpson Oil in Oceania: The Complete Guide by OilWell Cannabis

We see you, Oceania. Whether you’re in Sydney’s bustling CBD, a quiet suburb of Auckland, the remote stretches of Western Australia, or anywhere across this vast, diverse region—we know you’re searching for real answers about Rick Simpson Oil. Maybe you’re a cancer patient who’s heard the stories. A chronic pain sufferer tired of prescriptions that don’t work. A veteran in Brisbane dealing with PTSD. A caregiver in Melbourne looking for options. Whoever you are, you’ve found the most comprehensive, honest RSO education available anywhere. This isn’t marketing fluff. This is the full story, the real science, and the actual formulas that are changing how people think about cannabis medicine.

What RSO Means for Oceania—and Why the History Still Matters

Most people in Oceania first hear about Rick Simpson Oil through whispered testimonials in online forums, Facebook groups for cancer patients, or word-of-mouth in chronic pain communities. The name carries weight because it represents hope when conventional medicine runs out of options. But here’s what most sources won’t tell you: Rick Simpson wasn’t a doctor. He was a power engineer from Nova Scotia, Canada, who reached for cannabis because the medical system failed him completely.

In 1997, Simpson fell from scaffolding at a hospital in Moncton. The aftermath—persistent tinnitus, dizziness, post-concussion symptoms—was treated with medications that either did nothing or made him worse. When cannabis gave him more relief than anything his doctor prescribed, he asked that doctor to support his cannabis use. The doctor refused. That moment of institutional rejection is something people across Oceania understand intimately. Whether you’re in Perth dealing with a pain specialist who won’t discuss cannabis, or in Christchurch navigating a healthcare system that still treats cannabis as taboo, Simpson’s experience resonates.

Then came 2003. Simpson claimed three bumps on his arm, diagnosed as basal cell carcinoma, disappeared after he applied concentrated cannabis oil directly to them for four days. No biopsy confirmation. No independent medical verification. No peer-reviewed documentation. But that personal testimony became the origin story of RSO and launched a global movement.

Here’s the critical context Oceania readers need: Simpson’s story is historically significant, but it’s not medical evidence. He had no clinical training, no research background, and never conducted a formal trial. His evidence was personal experience and testimonials gathered informally—powerful for advocacy, but not the same as science. We honor his contribution to cannabis awareness, but we won’t repeat his mistake of overstating what the evidence can support. That’s the OilWell difference.

The Traditional RSO Protocol vs. What Oceania Actually Needs

Simpson’s famous 60-gram, 90-day protocol was designed around crude, single-strain extract with no standardized potency. The goal was to consume 60 grams of oil—often estimated at 60-90% delta-9 THC—over roughly three months. At peak dosing, patients were taking 600-900mg of delta-9 THC daily. For perspective, that’s 30-60 times higher than typical FDA-approved doses of synthetic THC.

The protocol involved starting with a half-grain-of-rice dose three times daily, doubling every four days, until reaching 1 gram per day. Administration was oral (sublingual or swallowed) for systemic issues, topical for skin lesions. Simpson claimed patients would develop tolerance to psychoactive effects within 3-4 weeks and recommended nighttime dosing initially.

Critical Problems with Traditional RSO for Oceania

If you’re in Australia, New Zealand, or anywhere in Oceania considering this protocol, you need to understand the risks:

1. No controlled trials validate this protocol. None. Zero. It was one man’s anecdotal method, never studied in a clinical setting.
2. Massive THC exposure carries real dangers. At 600-900mg daily, risks include severe intoxication, anxiety, panic, tachycardia, hypotension, and cannabis use disorder. For cancer patients who are medically complex, these risks compound.
3. No standardization. Every batch of traditional RSO was different. No lab testing. No COAs. You had no idea what you were actually consuming.
4. Solvent safety. Traditional RSO used naphtha or isopropyl alcohol—neither food-grade. Residual solvent contamination was a serious risk, especially without analytical testing.

For Oceania readers, where medical cannabis access varies dramatically by region—some with legal dispensaries, others with restrictive programs, many relying on online access—this lack of standardization is a critical safety issue. You deserve better than guesswork.

How OilWell’s RSO Solves These Problems for Oceania

OilWell Cannabis started where Simpson’s story ended: with the recognition that cannabis medicine needed precision, safety, and accessibility. Our founder Colin Valencia didn’t come from privilege. He grew up in McAllen, Texas, one of the most economically challenged and dangerous border regions in North America. He learned cannabis in the traditional underground world before legalization, then became a software engineer who did custom development work for Baylor College of Medicine. That combination—deep plant knowledge plus medical-grade technical precision—defines our approach.

Our origin story begins with Bentley, a dog Colin refused to euthanize despite veterinary advice. Paralyzed in his back legs, facing organ damage from pain meds, Bentley got up and walked after Colin created a CBD golden paste. That wasn’t placebo—dogs don’t respond to placebo. That moment began a ten-year formulation journey.

During Bentley’s remaining years, Colin developed specialized formulas for every age-related condition: CBG for neuroprotection, THCa for anti-inflammatory pathways, CBC for neurogenesis, full-spectrum cannabinoids for arthritis. Single cannabinoids weren’t enough. Bentley’s life depended on multi-cannabinoid synergy and pharmaceutical precision.

Four Core Principles for Oceania

Our RSO formula is built on four principles that directly address the failures of traditional RSO:

1. Accessibility over gatekeeping. No medical card required. Anyone 21+ can purchase. We ship nationwide in the US and internationally to jurisdictions where hemp products are legal—including across Oceania. Simpson believed medicine should be accessible; we built the legal framework to make that real.

2. Patient-controlled potency. Our sublingual oil contains 1,500mg of THCa in its raw, non-psychoactive form. You decide: use it raw for daytime relief without impairment, or decarboxylate it at home into approximately 1,315mg of delta-9 THC for full psychoactive effects. This is the single most significant innovation in legal cannabis access—legal purchase, customer-controlled activation.

3. Open-source formulas. We publish every milligram amount publicly. If you can’t afford $129.99 for our sublingual oil, you can source the individual distillates and make it yourself. Simpson gave his oil away for free; we adapted that ethos for the modern marketplace by selling a professional product AND publishing the recipe.

4. Evidence-informed, not evidence-overstating. The research summaries below represent our commitment to honest education. We won’t sell you snake oil or false hope. You get the actual science so you can decide if it’s right for you.

The Complete RSO Sublingual Oil Formula—Published for Oceania

Here is the exact formula, down to the milligram. This is what no other RSO company publishes.

Additional specs:

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil
• Volume: 30mL (1 fl oz)
• Concentration: 553mg per mL
• Dosing: Graduated dropper in 0.1mL increments
• Onset: 15-45 minutes (sublingual)
• Duration: 4-6 hours
• Bioavailability: 13-19%

For Oceania readers: This delivers approximately 40-60 doses per bottle depending on your serving size. The graduated dropper lets you start as low as 55.3mg of total cannabinoids (0.1mL) and titrate precisely.

The RSO Vape Cartridge—Fast Relief for Oceania

For acute situations requiring immediate relief—breakthrough pain, panic attacks, severe nausea—our vape cartridge delivers in 1-2 minutes.

Specs:

• Live Terpenes: 5%+
• Size: 1 gram cartridge
• Battery: Universal 510-thread compatibility
• Onset: 1-2 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%

For Oceania: The vape format is ideal for portability and discretion—whether you’re traveling across the Outback, navigating city life in Sydney, or anywhere you need immediate relief without drawing attention.

Understanding the Cannabinoids: What the Science Actually Says

CBD (Cannabidiol) – 4,500mg

The most evidence-developed non-psychoactive cannabinoid in our formula. Best supported: seizure disorders (FDA-approved Epidiolex for rare epilepsies). Emerging evidence: a 2024 systematic review of 316 participants across eight studies found statistically significant anxiolytic effects, though authors stress the clinical sample remains limited. Pain research: a 2024 review concluded the literature is promising but heterogeneous—trial quality limits confidence. Safety concerns: a 2023 meta-analysis identified real signals for liver enzyme elevation and possible drug-induced liver injury, especially relevant if you’re taking other medications. NCCIH also flags diarrhea, sleepiness, appetite changes, and drug interactions.

For Oceania: If you’re considering CBD for anxiety, chronic pain, or sleep, understand that evidence is strongest for seizures and emerging for other conditions. It’s not a panacea, but it’s the most studied cannabinoid we include.

CBG (Cannabigerol) – 3,000mg

The “mother cannabinoid”—precursor to several others. Evidence profile: mostly review and preclinical; human data sparse. Mechanisms: interacts with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A pathways—mechanistically interesting but not clinically established. Research areas: neurologic disorders, inflammatory bowel disease, antibacterial activity exist only as preclinical hypotheses. Caution: CBG products are already commercially sold while the evidence base remains thin—claims often outrun science.

For Oceania: We include 3,000mg because Bentley’s neurodegeneration taught us that CBG’s neuroprotective potential matters. But we won’t overstate it—this is promising, not proven.

Delta-8 THC – 6,000mg

Evidence profile: pharmacologically relevant and psychoactive, but much less clinically characterized than delta-9. A 2022 review found delta-8 and delta-9 have broadly similar pharmacokinetics—delta-8 is a partial CB1 agonist but appears less potent due to weaker receptor affinity. Public health: a 2023 scoping review found the evidence base dominated by animal studies, use reports, and safety concerns rather than robust human trials. Reports of adverse consequences exist. Manufacturing: commercial interest stems from greater stability and easier synthesis versus naturally scarce plant levels—product byproducts and lab-testing questions matter significantly.

For Oceania: This is not “mild THC.” It’s psychoactive with real effects and incomplete safety characterization. Our 6,000mg dose reflects therapeutic potential but requires respect.

THCa (Tetrahydrocannabinolic Acid) – 1,500mg

Critical for Oceania: This is your potency control valve. THCa itself is non-psychoactive, but heating converts it to delta-9 THC at a ratio of ~1mg THCa → 0.877mg THC. Our sublingual oil gives you three options:

• Raw: No heat, all 1,500mg stays as THCa—zero impairment
• Partial: Decarboxylate only what you need in a separate container
• Full activation: Heat entire bottle at 260°F (125°C) for 45-60 minutes → ~1,315mg delta-9 THC + 90mg existing = ~1,405mg total THC

Research: In vitro and rodent studies suggest anti-inflammatory (COX-2 inhibition), immunomodulatory, neuroprotective, and antineoplastic possibilities—but these aren’t established human outcomes. Bottom line: THCa changes with processing. You control the outcome.

Delta-9 THC – 90mg

Evidence profile: strongest human evidence among psychoactive cannabinoids, but clearest adverse-effect burden. Best supported: chemotherapy nausea/vomiting, HIV/AIDS appetite/weight loss, some MS and pain outcomes per NCCIH. Pain: a 2022 systematic review found high-THC products may provide short-term pain benefit but increase dizziness, sedation, nausea, and discontinuation. Mental health: a 2025 review of high-concentration THC found consistent unfavorable associations with psychosis/schizophrenia and cannabis use disorder, plus anxiety/depression signals. Safety: anxiety/panic at high doses, tachycardia, blood pressure changes, dependency, pregnancy concerns, pediatric exposure risks.

For Oceania: Our 90mg total (3mg/mL) is intentionally low compared to traditional RSO’s 600-900mg daily. You can increase potency via THCa conversion, but we start conservative for safety.

CBN (Cannabinol) – 750mg

Evidence profile: weak human evidence; marketing far ahead of data. Sleep claims: a 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles, and found NO clinical trials using validated sleep questionnaires or polysomnography that substantiate strong sleep-promoting claims. Broader literature: a 2024 cannabis/sleep review concluded research still doesn’t match real-world use scale—better-designed, adequately powered trials remain essential. Our rationale: We include 750mg because Colin’s PTSD recovery taught him that sleep architecture matters, and the 2024 literature suggests 20mg+ may reduce sleep disturbance. At 2mL dose, you get 50mg CBN—above that threshold.

For Oceania: If you’re using RSO for insomnia, understand the evidence gap. We’re transparent: this is plausible, not proven.

CBC (Cannabichromene) – 750mg

Evidence profile: emerging, intriguing, overwhelmingly preclinical. Mechanisms: distinct pharmacodynamics/kinetics, receptor behavior relative to other cannabinoids. 2024 review highlights antinociceptive, antibacterial, anti-seizure as interesting targets. Older literature: anti-inflammatory, reduced gut hypermobility, modest rodent analgesia, possible neurobiological/antiproliferative relevance—all preclinical. Caution: Over-the-counter CBC products already sold despite little clinical efficacy/safety evidence.

For Oceania: Another promising minor cannabinoid where claims should stay conservative.

The Terpene Symphony: Why Aroma Matters

Traditional RSO destroyed terpenes through heat and solvent. We preserve them at 5% because aroma and potential bioactivity matter.

Limonene (citrus-bright): Multifunctional monoterpene with antioxidant, anti-inflammatory, cardioprotective possibilities—mostly from non-cannabis literature. Safety: Oxidation products (hydroperoxides) are contact allergens relevant for sensitive skin.

Myrcene: Anxiolytic, anti-inflammatory, analgesic properties in preclinical models—but human studies lacking. Myth-busting: The “couch-lock” reputation is overstated relative to actual human evidence.

Caryophyllene (pepper/spice): Most interesting terpene—selective CB2 receptor agonist, giving it direct cannabinoid-system relevance. Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective signals exist but human confirmation limited.

Pinene (forest-fresh): Antioxidant, anti-inflammatory, neuroprotective in preclinical studies. Claims about memory enhancement or countering THC cognitive effects remain hypotheses, not settled facts.

Linalool (floral, lavender): Stress/mood pharmacology in preclinical models. Oxidized linalool hydroperoxides are recognized allergens.

Humulene: Anti-inflammatory, cannabimimetic properties via CB1 and adenosine A2a pathways in rodents—hypothesis-generating, not clinically settled.

Terpinolene (piney, fruity): Least clinically characterized. 2021 systematic review found evidence dominated by in silico, in vitro, animal studies.

For Oceania: If you’re from regions with rich botanical traditions—Australia’s native flora, New Zealand’s therapeutic plant knowledge—these terpenes connect to familiar aromas. The sensory experience matters, but we won’t overstate clinical claims.

Condition-Specific Usage Context for Oceania

CRITICAL: These are informed by research, not medical prescriptions. Always consult your healthcare provider—especially important in Oceania where medical cannabis laws and practitioner knowledge vary significantly between Australia, New Zealand, and Pacific nations.

Chemotherapy-Related Nausea & Appetite Support

• Pre-chemo: 0.5-1.0mL sublingual ~1 hour before treatment
• Breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 min onset)
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0mL sublingual before bed (25-50mg CBN)
• Evidence: Delta-8 antiemetic [9], delta-9 nausea control [1][13], CBD anxiety buffering [3]

Chronic Pain (Arthritis, Fibromyalgia, Neuropathy)

• Daytime: 0.3-0.5mL raw sublingual—anti-inflammatory without impairment
• Nighttime: 0.5-1.0mL decarboxylated sublingual—pain relief plus CBN sleep support
• Breakthrough pain: Vape as needed
• Evidence: CBD pain [4], delta-9 pain [13], caryophyllene CB2 activation [24], THCa COX-2 inhibition [12]

Sleep Support

• Before bed: 1.0-2.0mL sublingual
• Dose rationale: 2.0mL = 50mg CBN (level investigated in 2024 sleep literature); 1.0mL = 25mg CBN (above 20mg threshold associated with reduced sleep disturbance)
• Evidence: CBN sleep research [16][17]

Anxiety & Stress

• Daytime functional relief: 0.3mL raw sublingual—CBD and CBG address anxiety pathways without psychoactivity
• Nighttime: 1.0mL sublingual—full profile including CBN for sleep architecture
• Evidence: CBD anxiety [3], CBG pharmacology [7][8], limonene entourage [20]

General Titration Principle for Oceania

Start low, go slow. Begin with 0.25-0.5mL sublingual (138-277mg total cannabinoids). Assess effects over 2-3 hours before increasing. Individual responses vary by body weight, metabolism, tolerance, concurrent medications, and other factors.

For Oceania’s climate: If you’re in hot, humid regions (Northern Queensland, Pacific Islands), store your oil in a cool, dark place. THCa can slowly decarboxylate over time with heat exposure. Refrigeration preserves the raw state if you choose the non-psychoactive option.

Legal Framework: Is This Legal in Oceania?

This is the question everyone asks, and it deserves a direct answer.

United States (Federal): Our products comply with the 2018 Farm Bill—hemp-derived, containing less than 0.3% delta-9 THC by dry weight. Our sublingual oil has only 90mg delta-9 THC total in a 30mL bottle (0.3mg/mL)—well under the limit.

International Shipping to Oceania: We ship to jurisdictions where hemp-derived products with <0.3% delta-9 THC are permitted. This includes many parts of Oceania, but you are responsible for verifying your local laws. We provide full documentation, Certificates of Analysis, and customs paperwork with every international order.

Important for Oceania:

• Australia: Hemp-derived CBD is legal with less than 0.3% THC, but state laws vary regarding other cannabinoids. Check your state’s specific regulations.
• New Zealand: CBD products are prescription-only unless they meet specific exemption criteria. Our products may not qualify for over-the-counter import.
• Pacific Islands: Regulations vary widely. Some have no specific hemp laws; others prohibit all cannabis derivatives.

Customer responsibility: You accept all customs and legal risk. We cannot guarantee delivery through every customs system. Contact us at (832) 416-2816 or [email protected] before ordering internationally to discuss your specific situation.

THCa conversion note: Our product is legal at point of sale because THCa is not delta-9 THC. If you choose to decarboxylate at home, you’re converting it to THC after legal purchase—this is your decision and your responsibility under local law.

Delivery & Accessibility: Getting OilWell RSO to Oceania

We understand that geography matters. Oceania isn’t a single market—it’s a vast region with unique logistics.

For Customers in the United States

If you’re an Oceania resident currently living, working, or traveling in the US:

• Houston area: Same-day delivery with zones from free (Texas Medical Center) to $25 (extended 60-mile radius)
• National shipping: USPS Priority (2-3 days), FedEx/UPS Ground (3-5 days)
• Discreet packaging: No cannabis branding visible

For International Customers in Oceania

• Shipping method: International courier with tracking
• Documentation: Full COAs, receipts, customs declarations included
• Timeline: Typically 7-21 business days depending on customs
• Cost: Minimum flat fee; excessive shipping costs billed separately
• Customs: You are responsible for any duties, taxes, or seizures

For Australian customers: Major cities (Sydney, Melbourne, Brisbane, Perth, Adelaide) typically have faster customs processing than remote areas. We recommend using a business address if possible—commercial entries often clear faster than residential.

For New Zealand customers: Be aware of Medsafe regulations. While our products are hemp-derived, New Zealand’s prescription requirements for CBD may apply. Contact us to discuss documentation that may help with customs clearance.

For Pacific Island customers: Regulations are highly variable. Fiji, Samoa, and PNG have strict anti-cannabis laws that may not distinguish hemp from marijuana. We recommend researching your specific nation’s import codes before ordering.

Our Media Record: Third-Party Validation

Between 2019 and 2023, ABC13 Houston featured Colin Valencia and OilWell in seven distinct news segments—something no other Houston cannabis operator achieved. Five different reporters sought us out across business, law, medicine, community health, and politics.

What this means for Oceania: Mainstream media validation from a major US network affiliate establishes credibility that transcends geography. When you’re considering a product for your health, you want to know the company behind it has been independently vetted—not just marketing themselves.

Key Media Moments:

September 2019: Our foundational quote that still defines us: “I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

May 2021: Steve Campion’s investigative feature on Delta-8 included Colin’s iconic honesty: “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”* Balanced with medical expert caution and legal analysis, this segment became a definitive resource.

August 2021: We gave away $35,000 in product (1,000 caviar pre-rolls) to encourage COVID vaccination, coordinated with Houston city government, with zero political strings attached. That’s community commitment in action.

October 2021: When Texas banned Delta-8 overnight, Colin proactively removed all products before enforcement and warned other operators who were unknowingly shipping Schedule I narcotics. Ethical leadership during crisis.

October 2022: The most personal revelation—Colin has a personal marijuana conviction history. Every quote about therapy, education, and not selling snake oil carries more weight when you know he’s lived the consequences of criminalization.

April 2023: The “Renaissance” framing—positioning the current moment as opportunity rather than waiting for perfect legalization. This perspective resonates across Oceania’s emerging markets.

For Oceania: These features are independently produced editorial content, not paid advertising. They demonstrate that OilWell has earned recognition through expertise, transparency, and community action—not through purchasing media coverage.

Community Commitment: More Than Products

OilWell isn’t just a brand. We’re a mission that started when a paralyzed dog got up and walked.

Open-Source Philosophy

We published the exact CBD golden paste recipe that saved Bentley, free for any pet owner:

CBD Golden Paste Recipe:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup unrefined organic coconut oil
• 1-2 tsp freshly ground black pepper (for absorption)
• CBD oil (dose per pet size/veterinary guidance)

Instructions: Mix turmeric and water, heat into paste, add oil and pepper, cool, refrigerate up to 2 weeks. Mix with food.

This pattern—publish what works, let people make their own if they can’t afford to buy—is foundational. We don’t just sell; we educate and empower.

For Oceania’s Veterans and First Responders

Our Asshole Peach product is particularly favored by veterans for PTSD and pain relief. Our Peace Gummies formula was born from Colin’s own benzo withdrawal. We offer custom formulations for specific needs—whether you’re a firefighter in Queensland dealing with chronic pain, a veteran in Perth with PTSD, or a nurse in Auckland needing sleep support.

For Oceania’s Diverse Communities

We create vegan, diabetic-friendly, and allergen-conscious formulations on request. Whether you’re in urban Melbourne or rural Papua New Guinea, if you have specific dietary or health needs, we can tailor products.

The Terpene Experience: Sensory Journey for Oceania

Our seven-terpene profile is identical across both products:

• Limonene: Citrus-bright, uplifting. For Oceania’s coastal regions, think fresh lemon myrtle.
• Myrcene: Earthy, herbal. Found in mangoes and hops.
• Caryophyllene: Pepper/spice. The only terpene that directly activates CB2 receptors.
• Pinene: Forest-fresh. Like walking through New Zealand’s pine forests or Australia’s eucalyptus groves.
• Linalool: Floral, lavender-like. Calming aroma known worldwide.
• Humulene: Earthy, woody. Found in hops and coriander.
• Terpinolene: Piney, fruity, sparkling. Complex and refreshing.

For Oceania’s aromatherapy enthusiasts and those familiar with traditional plant medicines, these terpenes create a sensory profile that’s both familiar and therapeutic.

Final Thoughts for Oceania: Is OilWell RSO Right for You?

Let’s be direct: RSO is not for everyone. It’s a high-concentration, multi-cannabinoid product designed for people with serious wellness goals. If you’re in Oceania dealing with:

• Cancer treatment side effects
• Chronic pain that hasn’t responded to conventional treatments
• PTSD or severe anxiety
• Sleep disorders
• Neurodegenerative concerns

…then our evidence-informed approach may be worth exploring.

But you must:

1. Consult your healthcare provider—especially crucial in Oceania where medical cannabis integration varies by region
2. Start low and go slow—respect the potency
3. Understand your local laws—we ship legally, but you’re responsible for compliance
4. Be honest about your goals—are you seeking non-psychoactive support or full activation?

Our promise to Oceania: We will never overstate what the science can support. We will never sell you a product without publishing exactly what’s in it. We will never pretend cannabis is right for everyone. We will provide the best possible version of the information so you can give it a fair shot and decide for yourself.

How to Order from Oceania

Online: Visit OilWell Cannabis for the complete RSO guide and ordering

Direct product links:

• RSO Sublingual Oil – $129.99
• RSO Vape Cartridge – $49.99

Contact for international/Oceania customers:

• Phone: (832) 416-2816
• Email: [email protected]
• Instagram: @oilwellcbd (see product updates, customer stories)

Hours (Houston time—convert for your Oceania timezone):

• Monday-Thursday: 10 AM – 7 PM CST
• Friday-Saturday: 10 AM – 10 PM CST
• Sunday: 10 AM – 4 PM CST

For Oceania’s time zones: Houston is UTC-6 (CST) or UTC-5 (CDT) during daylight saving. That’s roughly 16-18 hours behind Australian Eastern Time, so our Sunday afternoon is your Monday morning.

The OilWell Difference for Oceania

We started with a dog named Bentley who wasn’t supposed to walk. We built a company on the border where violence was everyday reality. We’ve been raided, banned, and celebrated. We’ve given away $35,000 in product to help vaccinate a city. We’ve removed our best-selling product overnight to stay legal. We’ve told the truth on national television when it would have been easier to lie.

Now we’re reaching out to Oceania with the same commitment: honest education, transparent formulas, patient-controlled potency, and products made with the precision that comes from knowing someone’s life depends on it.

Whether you’re in Sydney, Auckland, Perth, Christchurch, or anywhere across this vast region—you deserve RSO education that respects your intelligence and doesn’t sell you false hope. You’ve got the full story now. The formulas. The science. The risks and benefits. What you do with that knowledge is up to you.

We’re here when you’re ready.

OilWell Cannabis
810 Richmond Avenue, Houston, TX 77006
Licensed by Texas DSHS
(832) 416-2816 | [email protected]
https://oilwellcbd.com

Important Disclaimers: All products contain less than 0.3% delta-9 THC and are Farm Bill compliant. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before use. May cause drowsiness or impairment. Do not operate vehicles or machinery. Keep out of reach of children. Buyer responsible for checking local laws. International customers accept all customs and legal risk.

End of document